Bcwm LLC Buys 1,742 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Bcwm LLC boosted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 42,915 shares of the exchange traded fund’s stock after acquiring an additional 1,742 shares during the period. Bcwm LLC owned 0.06% of SPDR S&P Biotech ETF worth $3,979,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the company. Greenwich Wealth Management LLC boosted its position in shares of SPDR S&P Biotech ETF by 10.3% in the second quarter. Greenwich Wealth Management LLC now owns 11,505 shares of the exchange traded fund’s stock valued at $1,067,000 after acquiring an additional 1,073 shares during the period. J.W. Cole Advisors Inc. boosted its holdings in SPDR S&P Biotech ETF by 0.8% during the second quarter. J.W. Cole Advisors Inc. now owns 36,284 shares of the exchange traded fund’s stock valued at $3,364,000 after purchasing an additional 279 shares in the last quarter. Envestnet Asset Management Inc. grew its stake in shares of SPDR S&P Biotech ETF by 12.5% in the 2nd quarter. Envestnet Asset Management Inc. now owns 186,400 shares of the exchange traded fund’s stock valued at $17,281,000 after purchasing an additional 20,685 shares during the period. PFG Advisors raised its holdings in shares of SPDR S&P Biotech ETF by 6.8% in the 2nd quarter. PFG Advisors now owns 78,342 shares of the exchange traded fund’s stock worth $7,263,000 after buying an additional 5,018 shares in the last quarter. Finally, BOKF NA lifted its position in shares of SPDR S&P Biotech ETF by 65.5% during the 2nd quarter. BOKF NA now owns 1,390 shares of the exchange traded fund’s stock worth $129,000 after buying an additional 550 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock opened at $101.21 on Monday. The stock’s fifty day simple moving average is $98.48 and its 200 day simple moving average is $93.85. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52. The firm has a market cap of $7.71 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.